Ensysce Biosciences Inc —— 季度资产负债表 (NASDAQ:ENSC) | MetaTrader

展开完整图表

新闻

Ensysce公布限制阿片类药物过量技术的一期临床数据

Ensysce publishes phase 1 data on overdose-limiting opioid tech

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.05%

美国股市收低；截至收盘道琼斯工业平均指数下跌1.05%

Tiny Pain-Focused Biotech Ensysce Biosciences Surges Amid Strategic Review - Ensysce Biosciences (NASDAQ:ENSC)

Ensysce Biosciences在3期疼痛药物试验中达到50%入组率

Ensysce Biosciences reaches 50% enrollment in Phase 3 pain drug trial

Ensysce Biosciences在巴西获得疼痛技术专利授权

Ensysce Biosciences receives patent allowance in Brazil for pain tech

Ensysce Biosciences, Inc. (ENSC) Shareholder/Analyst Call Prepared Remarks Transcript

Ensysce Biosciences advances phase 3 trial for abuse-resistant opioid

Ensysce Biosciences enrolls first patient in phase 3 pain drug trial